U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidelines and Recommendations

CDC Stacks Public Health Publications

CDC Guidelines and Recommendations are updated by various CDC centers and institutes in response to new scientific discoveries, to public health issues, and to disease outbreaks. Items in this collection may have been superceded or replaced. For the most up to date information, please visit the CDC home page at https://www.cdc.gov/ and search the Health Topic or Outbreak you are interested in.

(5)
(2)
(4)
(3)
(2)
(3)
(17)
(10)
(16)
(13)
(27)
(32)
(22)
(46)
(33)
(34)
(34)
(22)
(25)
(18)
(19)
(27)
(20)
(29)
(13)
(16)
(17)
(14)
(12)
(10)
(13)
(15)
(12)
(14)
(11)
(16)
(16)
(6)
(1)
(3)
(3)
(6)
(3)
(1)
(4)
(27)
(22)
(30)
(8)
(9)
(7)
(7)
0 of 52
(161)
(260)
(1)
(1)
(1)
(355)
0 of 6
(1)
(1)
(3)
(2)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(423)
(1)
(1)
0 of 27
(7)
(2)
(38)
(3)
(2)
(2)
(7)
0 of 7
(53)
(6)
(5)
(1)
(3)
(12)
(563)
(1)
(1)
(22)
(41)
(63)
0 of 12
(452)
(1)
(31)
(268)
(1)
0 of 5
(130)
(18)
0 of 2
(103)
(6)
0 of 2
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(74)
(1)
(5)
(1)
(1)
(1)
(87)
(1)
(1)
(7)
(1)
(2)
(35)
(2)
(7)
(1)
(5)
(2)
(1)
(1)
(3)
(3)
(3)
(4)
(1)
(2)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(32)
(6)
(1)
(6)
(3)
(11)
(2)
(3)
(2)
(4)
(2)
(2)
(2)
(1)
(8)
(1)
(2)
(1)
(4)
(2)
(3)
(3)
(1)
(9)
(8)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(14)
(3)
(4)
(1)
(2)
(1)
(3)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(2)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(10)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(4)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(6)
(1)
(3)
(1)
(1)
(2)
(13)
(1)
(1)
(2)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(2)
(11)
(1)
(2)
(1)
(4)
(2)
(4)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(6)
(2)
(2)
(1)
(91)
(76)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(6)
(2)
(3)
(1)
(9)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(13)
(3)
(3)
(10)
(4)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(3)
(1)
(2)
(4)
(4)
(5)
(3)
(2)
(2)
(2)
(1)
(1)
(11)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(7)
(4)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(5)
(3)
(3)
(1)
(1)
(1)
(1)
(2)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(10)
(1)
(1)
(10)
(2)
(2)
(2)
(3)
(1)
(2)
(1)
(1)
(14)
(2)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(6)
(1)
(24)
(1)
(20)
(18)
(1)
(1)
(3)
(1)
(5)
(2)
(2)
(7)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(8)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(7)
(2)
(2)
(5)
(3)
(8)
(2)
(3)
(2)
(4)
(3)
(6)
(2)
(2)
(2)
(2)
(22)
(2)
(14)
(2)
(3)
(5)
(2)
(2)
(5)
(3)
(3)
(5)
(4)
(2)
(2)
(4)
(4)
(3)
(4)
(64)
(2)
(3)
(2)
(2)
(2)
(4)
(2)
(3)
(4)
(2)
(3)
(2)
(2)
(4)
(2)
(4)
(2)
(3)
(3)
(2)
(2)
(3)
(14)
(8)
(2)
(7)
(3)
(7)
(2)
(4)
(2)
(15)
(3)
(3)
(5)
(12)
(4)
(2)
(2)
(2)
(4)
(3)
(5)
(3)
(2)
(3)
(3)
(2)
(4)
(2)
(6)
(6)
(3)
(2)
(8)
(5)
(4)
(2)
(2)
(2)
(2)
(7)
(7)
(6)
(2)
(3)
(3)
(31)
(2)
(6)
(3)
(4)
(2)
(6)
(2)
(2)
(13)
(13)
(10)
(2)
(5)
(7)
(5)
(3)
(2)
(2)
(2)
(2)
(5)
(224)
(2)
(2)
(2)
(9)
(7)
(2)
(18)
(2)
(2)
(7)
(7)
(4)
(9)
(98)
(2)
(10)
(2)
(3)
(4)
(2)
(3)
(5)
(3)
(3)
(83)
(30)
(29)
(7)
(3)
(9)
(2)
(3)
(3)
(3)
(4)
(5)
(20)
(10)
(9)
(3)
(14)
(6)
(2)
(12)
(4)
(11)
(2)
(10)
(2)
(16)
(5)
(2)
(2)
(21)
(18)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(5)
(5)
(2)
(3)
(8)
(3)
(3)
(3)
(3)
(3)
(3)
(2)
(4)
(2)
(2)
(2)
(13)
(3)
(4)
(42)
(4)
(2)
(2)
(2)
(16)
(3)
(9)
(5)
(8)
(9)
(2)
(2)
(9)
(15)
(2)
(2)
(43)
(2)
(2)
(4)
(8)
(8)
(5)
(2)
(3)
(6)
(2)
(2)
(13)
(14)
(2)
(28)
(2)
(122)
(4)
(2)
(2)
(4)
(4)
(4)
(11)
(5)
(6)
(5)
(2)
(2)
(2)
(5)
(4)
(2)
(4)
(10)
(3)
(2)
(4)
(2)
(2)
(2)
(5)
(2)
(3)
(22)
(3)
(6)
(2)
(2)
(3)
(2)
(23)
(6)
(3)
(60)
(3)
(22)
(2)
(4)
(6)
(2)
(2)
(2)
(6)
(2)
(2)
(3)
(2)
(2)
(2)
(6)
(2)
(6)
(2)
(14)
(5)
(5)
(4)
(4)
(3)
(18)
(9)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(18)
(2)
(2)
(16)
(3)
(10)
(2)
(6)
(2)
(7)
(3)
(2)
(3)
(5)
(7)
(2)
(5)
(3)
(2)
(7)
(13)
(20)
(38)
(3)
(4)
(2)
(2)
(3)
(3)
(2)
(3)
(5)
(118)
(2)
(7)
(3)
(3)
(10)
(2)
(6)
(2)
(2)
(3)
(2)
(4)
(6)
(2)
(2)
(2)
(2)
(17)
(3)
(3)
(2)
(5)
(3)
(2)
(2)
(7)
(3)
(6)
(2)
(4)
(2)
(2)
(2)
(4)
(15)
(7)
(7)
(3)
(3)
(2)
(3)
(3)
(2)
(2)
(4)
(2)
(2)
(5)
(3)
(2)
(3)
(5)
(3)
(2)
(2)
(2)
(4)
(6)
(3)
(2)
(2)
(2)
(6)
(2)
(2)
(2)
(2)
(14)
(2)
(2)
(8)
(18)
(3)
(5)
(4)
(2)
(4)
(6)
(2)
(2)
(2)
(2)
(3)
(3)
(2)
(86)
(2)
(24)
(15)
(2)
(8)
(16)
(11)
(11)
(15)
(2)
(12)
(2)
(3)
(3)
(2)
(14)
(3)
(6)
(4)
(4)
(8)
(6)
(3)
(2)
(2)
(2)
(10)
(3)
(2)
(3)
(9)
(2)
(4)
(5)
(2)
(2)
(2)
(2)
(2)
(17)
(5)
(4)
(3)
0 of 1000
(4)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(13)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(11)
(1)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(2)
(1)
(4)
(9)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(1)
(2)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(4)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(3)
(4)
(3)
(2)
(7)
(4)
(2)
(2)
(5)
(2)
(2)
(5)
(2)
(3)
(3)
(3)
(3)
(3)
(4)
(2)
(5)
(3)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(4)
(9)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(6)
(2)
(2)
(2)
(3)
(3)
(2)
(6)
(4)
(2)
(5)
(5)
(8)
(2)
(2)
(4)
(3)
(4)
0 of 1000
(1)
(6)
(1)
(1)
(2)
(3)
(19)
(4)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(17)
(8)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(4)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(23)
(1)
(2)
(1)
(1)
(3)
(22)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(275)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(6)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(2)
(4)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(11)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(4)
(2)
(4)
(6)
(2)
(5)
(2)
(3)
(1)
(22)
(1)
(3)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(2)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(6)
(1)
(1)
(1)
(11)
(4)
(1)
(4)
(4)
(4)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(8)
(6)
(4)
(9)
(19)
(3)
(1)
(1)
(1)
(4)
(6)
(1)
(5)
(3)
(1)
(1)
(1)
(4)
(1)
(1)
(15)
(7)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(3)
(1)
(1)
(4)
(1)
(2)
(1)
(8)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(9)
(3)
(7)
(1)
(1)
(111)
(4)
(2)
(19)
(1)
(5)
(9)
(1)
(2)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(10)
(1)
(1)
(1)
(3)
(8)
(1)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(125)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(4)
(1)
(9)
(1)
(1)
(3)
(1)
(1)
(1)
0 of 454
(1)
(3)
(10)
(1)
(5)
(2)
(1)
(1)
(155)
(3)
(1)
(1)
(1)
(28)
(3)
(1)
(1)
(149)
(1)
(45)
(1)
(124)
(5)
(1)
(5)
(1)
(4)
0 of 27
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 19
Showing 101 - 120 of 779 results
  • FoodCORE model practice laboratory timeliness and completeness
    FoodCORE model practice : laboratory timeliness and completeness
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne Waterborne, and Environmental Diseases.
    March 2014
    This FoodCORE Model Practice summarizes the successful laboratory practices used by PHLs in the FoodCORE centers for improving and maintaining the timeliness and completeness of isolate or specimen submissions to the PHL, the subtyping of enteric pathogens, and the communication of laboratory results and cluster detection reports. The activities de ...
    Current Public Domain
  • Recommended immunization schedules for persons aged 0 through 18 years United States 2014
    Recommended immunization schedules for persons aged 0 through 18 years United States, 2014
    United States. Advisory Committee on Immunization Practices.  ...
    January 1, 2014
    This schedule includes recommendations in effect as of January 1, 2014. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Vaccination providers should consul ...
    Superseded Public Domain
  • CDC Guidance for Evaluating HealthCare Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management
    CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management
    Schillie, Sarah F. ;
    Murphy, Trudy V.
    December 20, 2013 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report contains CDC guidance that augments the 2011 recommendations of the Advisory Committee on Immunization Practices (ACIP) for evaluating hepatitis B protection among health-care personnel (HCP) and administering post-exposure prophylaxis. Explicit guidance is provided for persons working, training, or volunteering in health-care settings ...
    Superseded Public Domain
  • Seeking Best Practices A Conceptual Framework for Planning and Improving EvidenceBased Practices
    Seeking Best Practices: A Conceptual Framework for Planning and Improving Evidence-Based Practices
    Spencer, Lorine M. ;
    Schooley, Michael W.
    Dec 12 2013 | Prev Chronic Dis. 10.
    How can we encourage ongoing development, refinement, and evaluation of practices to identify and build an evidence base for best practices? On the basis of a review of the literature and expert input, we worked iteratively to create a framework with 2 interrelated components. The first - public health impact - consists of 5 elements: effectiveness ...
    Current Supporting Files Public Domain
  • Clarifications to the VSP 2011 operations manual December 2013 revision
    Clarifications to the VSP 2011 operations manual. December 2013 revision
    Vessel Sanitation Program (U.S.)  ...
    Decmber 2013
    The following item numbers are being clarified in response to industry questions. Text from the VSP 2011 Operations Manual is printed first, then the clarification.
    Current Public Domain
  • Clarifications to the VSP 2011 construction guidelines December 2013 revision
    Clarifications to the VSP 2011 construction guidelines. December 2013 revision
    Vessel Sanitation Program (U.S.)  ...
    Decmber 2013
    The following item numbers are being clarified in response to industry questions. Text from the VSP 2011 Construction Guidelines is printed first, then the clarification.
    Current Public Domain
  • Dear Colleague Letter from Division of HIVAIDS Prevention Centers for Disease Control and Prevention to HIV Surveillance Coordinators AIDS Directors State Epidemiologisits State Health Officers and State Public Health Lab Directors about laboratory reporting of HIVrelated tests incluidng all CD4 Tlymphoyte CD4 results and all viral load test results
    Dear Colleague Letter from Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, to HIV Surveillance Coordinators, AIDS Directors, State Epidemiologisits, State Health Officers, and State Public Health Lab Directors about laboratory reporting of HIV-related tests, incluidng all CD4+ T-lymphoyte (CD4) results and all viral load test results
    Castro, Kenneth G. ;
    Lansky, Amy
    November 21, 2013
    Measuring progress towards goals of the National HIV/AIDS Strategy (NHAS) relies on laboratory reporting of HIV-related tests to the local and national HIV surveillance systems. The Centers for Disease Control and Prevention (CDC) recommends reporting of all HIV-related test results, including CD4+ T-lymphocyte (CD4) results and all viral load test ...
    Current Public Domain
  • Use of Japanese encephalitis vaccine in children recommendations of the Advisory Committee on Immunization Practices 2013
    Use of Japanese encephalitis vaccine in children : recommendations of the Advisory Committee on Immunization Practices, 2013
    Bocchini, Joseph A. ;
    Rubin, Lorry
    November 15, 2013 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include children aged 2 months through 16 years. The ACIP JE Vaccine Workgroup reviewed the epidemiology of J ...
    Current Public Domain
  • Voluntary guidelines for managing food allergies in schools and early care and education programs
    Voluntary guidelines for managing food allergies in schools and early care and education programs.
    Hunt, Pete
    10/31/2013
    These guidelines, Voluntary Guidelines for Managing Food Allergies in Schools and Early Care and Education Programs (hereafter called the Voluntary Guidelines for Managing Food Allergies), were developed in response to Section 112 of the FDA Food Safety Modernization Act, which was enacted in 2011. This act is designed to improve food safety in the ...
    Current Public Domain
  • Voluntary guidelines for managing food allergies in schools and early care and education programs frequently asked questions
    Voluntary guidelines for managing food allergies in schools and early care and education programs : frequently asked questions.
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Population Health.  ...
    10/31/2013
    A FAQ explaining the Voluntary guidelines for managing food allergies in schools and early care and education programs issued Oct. 2013 by the National Center for Chronic Disease Prevention and Health Promotion Division of Population Health.General Questions: What is a food allergy? -- What are symptoms of an allergic reaction to food? -- What is a ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports October 25 2013 Vol 62 No RR9
    Morbidity and Mortality Weekly Report: Recommendations and Reports, October 25, 2013 / Vol. 62 / No. RR-9
    Mase, Sundari ;
    Chorba, Terence
    October 25, 2013 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report provides provisional CDC guidelines for FDA-approved and unapproved, or off-label, uses of bedaquiline in certain populations, such as children, pregnant women, or persons with extrapulmonary MDR TB who were not included in the clinical trials for the drug. CDC's Division of TB Elimination developed these guidelines on the basis of expe ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports September 27 2013 Vol 62 No RR8
    Morbidity and Mortality Weekly Report: Recommendations and Reports, September 27, 2013 / Vol. 62 / No. RR-8
    Ikeda, Robin ;
    Qualters, Judith R.
    September 27, 2013 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report augments guidelines published in 1990 for investigating clusters of health events (CDC. Guidelines for investigating clusters of health events. MMWR 1990;39[No. RR-11]). The 1990 Guidelines considered any noninfectious disease cluster, injuries, birth defects, and previously unrecognized syndromes or illnesses. These new guidelines focu ...
    Current Public Domain
  • Updated US Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis
    Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis.
    Kuhar, David T. ;
    Henderson, David K.
    9/25/2013
    Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP). Please see attached statement (PDF of Dolutegravir attached).Several corrections have been made to this PDF since online publication of the “Updated US Public Health Service Guidelines for the Management of Occupati ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports September 20 2013 Vol 62 No RR7
    Morbidity and Mortality Weekly Report: Recommendations and Reports, September 20, 2013 / Vol. 62 / No. RR-7
    Grohskopf, Lisa A. ;
    Shay, David K.
    September 20, 2013 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report updates the 2012 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccines for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2012;61:613-8 ...
    Superseded Public Domain
  • Guidance for Cruise Ships on the Management of Varicella Chickenpox 2013
    Guidance for Cruise Ships on the Management of Varicella (Chickenpox) [2013]
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Global Migration and Quarantine.
    August 1, 2013
    In most years, varicella, commonly known as chickenpox, is the most common vaccine-preventable disease reported by cruise ships to the CDC Division of Global Migration and Quarantine (DGMQ). It is a frequent cause of outbreaks onboard cruise ships. Varicella is highly communicable, and secondary attack rates can be as high as 90%. Complications occ ...
    Current Public Domain
  • Update on recommendations for use of VariZIG United States 2013
    Update on recommendations for use of VariZIG — United States, 2013
    Marin, Mona ;
    Bialek, Stephanie R.
    July 19, 2013 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In December 2012, the Food and Drug Administration (FDA) approved VariZIG, a varicella zoster immune globulin preparation (Cangene Corporation, Winnipeg, Canada) for use in the United States for postexposure prophylaxis of varicella for persons at high risk for severe disease who lack evidence of immunity to varicella* and for whom varicella vaccin ...
    Current Public Domain
  • Security guidance for select agent or toxin facilities 7 CFR Part 331 9 CFR Part 121 42 CFR Part 73
    Security guidance for select agent or toxin facilities : 7 CFR Part 331, 9 CFR Part 121, 42 CFR Part 73
    Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins.  ...
    5 July, 2013
    Section 201 of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (P.L. 107- 188)(the Act) requires the Secretary of the Department of Health and Human Services (HHS) to, by regulation, provide for “the appropriate safeguard and security requirements for persons possessing, using, or transferring a listed agent or tox ...
    Current Public Domain
  • Guidelines for treatment of malaria in the United States
    Guidelines for treatment of malaria in the United States
    Center for Global Health (U.S.)  ...
    July 1, 2013
    (Based on drugs currently available for use in the United States – updated July 1, 2013)
    Current Public Domain
  • FoodCORE model practice initial casepatient interviewing
    FoodCORE model practice : initial case-patient interviewing.
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne Waterborne, and Environmental Diseases.
    6/28/2013
    The FoodCORE Model Practice: Initial Case-patient Interviewing is intended to describe the basic practices and characteristics of conducting comprehensive interviews for all enteric disease case-patients upon initial identification or first contact, not just those identified as part of a local cluster or multistate cluster. The activities described ...
    Current Public Domain
  • Emergency Room Procedures in Chemical Hazard Emergencies A Job Aid 2013
    Emergency Room Procedures in Chemical Hazard Emergencies: A Job Aid [2013]
    National Center for Environmental Health (U.S.).
    June 25, 2013
    Preparations; When Victim Arrives; Initial Treatment; Nerve Agent Protocol; Chlorine Protocol; Lewisite Protocol; Phosgene Protocol; Mustard ProtocolWeb page; date may change.
    Current Public Domain
101 - 120 / 779